These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8195611)
21. In vivo biological effects of recombinant soluble interleukin-4 receptor. Maliszewski CR; Sato TA; Davison B; Jacobs CA; Finkelman FD; Fanslow WC Proc Soc Exp Biol Med; 1994 Jul; 206(3):233-7. PubMed ID: 8016157 [TBL] [Abstract][Full Text] [Related]
22. Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptor. Jacobs CA; Lynch DH; Roux ER; Miller R; Davis B; Widmer MB; Wignall J; VandenBos T; Park LS; Beckmann MP Blood; 1991 Jun; 77(11):2396-403. PubMed ID: 2039820 [TBL] [Abstract][Full Text] [Related]
23. H-2D haplotype-linked expression and involvement of TNF-alpha in Th2 cell-mediated tissue inflammation. Müller KM; Lisby S; Arrighi JF; Grau GE; Saurat JH; Hauser C J Immunol; 1994 Jul; 153(1):316-24. PubMed ID: 8207244 [TBL] [Abstract][Full Text] [Related]
24. Soluble IL-4 receptor, potential for therapeutic and prophylactic intervention. Gessner A; Röllinghoff M Behring Inst Mitt; 1994 Dec; (95):35-41. PubMed ID: 7755507 [TBL] [Abstract][Full Text] [Related]
25. Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro. Jung T; Wagner K; Neumann C; Heusser CH Eur J Immunol; 1999 Mar; 29(3):864-71. PubMed ID: 10092089 [TBL] [Abstract][Full Text] [Related]
26. Evidence for mouse Th1- and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation. Bass H; Mosmann T; Strober S J Exp Med; 1989 Nov; 170(5):1495-511. PubMed ID: 2572669 [TBL] [Abstract][Full Text] [Related]
27. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Renz H; Bradley K; Enssle K; Loader JE; Larsen GL; Gelfand EW Int Arch Allergy Immunol; 1996 Feb; 109(2):167-76. PubMed ID: 8563492 [TBL] [Abstract][Full Text] [Related]
28. Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4. Ma Y; Hurst HE; Fernandez-Botran R J Pharmacol Exp Ther; 1996 Oct; 279(1):340-50. PubMed ID: 8859012 [TBL] [Abstract][Full Text] [Related]
29. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro. Maliszewski CR; Sato TA; Vanden Bos T; Waugh S; Dower SK; Slack J; Beckmann MP; Grabstein KH J Immunol; 1990 Apr; 144(8):3028-33. PubMed ID: 2139075 [TBL] [Abstract][Full Text] [Related]
30. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. Bistoni F; Cenci E; Mencacci A; Schiaffella E; Mosci P; Puccetti P; Romani L J Infect Dis; 1993 Dec; 168(6):1449-57. PubMed ID: 8245528 [TBL] [Abstract][Full Text] [Related]
31. Effect of a combination therapy between IL-12 and soluble IL-4 receptor (sIL-4R) on Candida albicans and herpes simplex virus type I infections in thermally injured mice. Kobayashi M; Takahashi H; Herndon DN; Pollard RB; Suzuki F Can J Microbiol; 2002 Oct; 48(10):886-94. PubMed ID: 12489778 [TBL] [Abstract][Full Text] [Related]
32. Soluble human interleukin-4 receptor is produced by activated T cells under the control of metalloproteinases. Jung T; Schrader N; Hellwig M; Enssle KH; Neumann C Int Arch Allergy Immunol; 1999 May; 119(1):23-30. PubMed ID: 10341317 [TBL] [Abstract][Full Text] [Related]
33. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D). König B; Fischer A; König W Immunology; 1995 Aug; 85(4):604-10. PubMed ID: 7558156 [TBL] [Abstract][Full Text] [Related]
34. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody. Finkelman FD; Urban JF; Beckmann MP; Schooley KA; Holmes JM; Katona IM Int Immunol; 1991 Jun; 3(6):599-607. PubMed ID: 1888709 [TBL] [Abstract][Full Text] [Related]
35. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Varkila K; Chatelain R; Leal LM; Coffman RL Eur J Immunol; 1993 Jan; 23(1):262-8. PubMed ID: 8419179 [TBL] [Abstract][Full Text] [Related]
37. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model. Rupa P; Mine Y Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843 [TBL] [Abstract][Full Text] [Related]
38. A Recombinant DNA Plasmid Encoding the sIL-4R-NAP Fusion Protein Suppress Airway Inflammation in an OVA-Induced Mouse Model of Asthma. Liu X; Fu G; Ji Z; Huang X; Ding C; Jiang H; Wang X; Du M; Wang T; Kang Q Inflammation; 2016 Aug; 39(4):1434-40. PubMed ID: 27209195 [TBL] [Abstract][Full Text] [Related]
39. Detection of and discrimination between total and free human interleukin-4 and free soluble interleukin-4 receptor by ELISA. Jung T; Bews JP; Enssle KH; Wagner K; Neumann C; Heusser CH J Immunol Methods; 1998 Aug; 217(1-2):41-50. PubMed ID: 9776573 [TBL] [Abstract][Full Text] [Related]